Ascendis Pharma AS logo

Ascendis Pharma AS - ADR

NEW
FRA:A71 (Denmark)   ADR
€ 206 +2 (+0.98%) Apr 17
19.81
P/B:
10.00
Market Cap:
€ 12.74B ($ 14.88B)
Enterprise V:
€ 13.00B ($ 15.18B)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Ascendis Pharma AS logo
Ascendis Pharma AS
NAICS : 325412 SIC : 2836
ISIN : DK0060615755

Share Class Description:

FRA:A71: ADR

Total Employee Number:

1,189
Description
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt
1.81
Equity-to-Asset
0.63
Debt-to-Equity
0.31
Debt-to-EBITDA
1.9
Interest Coverage
2.15
Piotroski F-Score
7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
10.24
Distress
Grey
Safe
Beneish M-Score
2.85
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
60.08
9-Day RSI
60.16
14-Day RSI
58.43
3-1 Month Momentum %
9.29
6-1 Month Momentum %
14.94
12-1 Month Momentum %
42.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
2.99
Quick Ratio
2.32
Cash Ratio
1.75
Days Inventory
1225.15
Days Sales Outstanding
53.74
Days Payable
356.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-2.4
Shareholder Yield %
0.83

GF Valueâ„¢

Ascendis Pharma AS Filings

Filing Date Document Date Form
No Filing Data

Ascendis Pharma AS Stock Events

Financials Calendars
Event Date Price (€)
Fourth quarter earnings conference call for 2026 2027-02-11 16:30 In 171 days
Annual report for 2026 2027-02-11 In 170 days
Fourth quarter earnings results for 2026 2027-02-11 In 170 days
Third quarter earnings conference call for 2026 2026-11-12 16:30 In 80 days
Third quarter earnings results for 2026 2026-11-12 In 79 days
Second quarter earnings conference call for 2026 2026-08-13 08:00 204.00 (+0.00%)
Second quarter earnings results for 2026 2026-08-13 204.00 (+0.00%)
First quarter earnings conference call for 2026 2026-05-07 08:00 204.00 (+0.00%)
First quarter earnings results for 2026 2026-05-07 204.00 (+0.00%)
TD Cowen 46th Annual Health Care Conference 2026-03-02 11:10 193.00 (+0.00%)
Show
Entries

Articles on Ascendis Pharma AS

No articles.